Axsome Therapeutics, Inc.
AXSM
$210.63
$2.811.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.31M | -64.54M | -28.56M | -47.23M | -47.97M |
| Total Depreciation and Amortization | 2.89M | 2.37M | 2.27M | 2.41M | 2.25M |
| Total Amortization of Deferred Charges | 164.00K | 159.00K | 161.00K | 158.00K | 317.00K |
| Total Other Non-Cash Items | 26.51M | 24.87M | 14.83M | 36.92M | 27.72M |
| Change in Net Operating Assets | -11.20M | 16.44M | -7.36M | 8.78M | -14.73M |
| Cash from Operations | -32.95M | -20.70M | -18.65M | 1.05M | -32.42M |
| Capital Expenditure | -450.00K | -121.00K | -71.00K | -58.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -450.00K | -121.00K | -71.00K | -58.00K | -13.00K |
| Total Debt Issued | 70.00M | 70.00M | 70.00M | 70.00M | 190.00M |
| Total Debt Repaid | -71.21M | -70.67M | -70.54M | -70.66M | -192.51M |
| Issuance of Common Stock | 55.44M | 16.32M | 21.01M | 25.47M | 44.29M |
| Repurchase of Common Stock | -2.83M | -9.30M | -1.04M | -842.00K | -888.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.25M | -3.36M | -3.04M | -2.70M | -6.36M |
| Cash from Financing | 48.15M | 2.99M | 16.39M | 21.27M | 34.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.74M | -17.83M | -2.34M | 22.26M | 2.11M |